Losing CD Markers After Dissociation? How Enzyme Choice Affects Surface Epitopes

CD marker loss after dissociation is one of the most common and least discussed sources of error in flow cytometry on solid tissue and adherent culture. A population looks negative, a gate moves, a sorted fraction underperforms — and the cause is not biology but the protease that released the cells 40 minutes earlier. This guide covers the mechanism, what the published comparisons actually measured, and the controls that tell an epitope artefact apart from a real change in expression.

Why dissociation enzymes remove surface markers

Antibodies bind a small, defined region of a protein. Removing or altering that region is enough to make a marker undetectable, even when the protein is still on the cell. Three mechanisms account for nearly all of it:

• Proteolytic cleavage. Trypsin and trypsin-like serine proteases cut after lysine and arginine. Any extracellular epitope containing an accessible lysine or arginine — or sitting next to one — can be cut off the cell surface. Broad-spectrum neutral proteases such as dispase cleave at many more sites and are correspondingly harsher on epitopes.
• Side activities in the preparation. Crude collagenase preparations carry variable amounts of clostripain, neutral protease and trypsin-like activity. Two lots of the same catalogue number can behave differently, which is why an enzyme that worked last year sometimes stops working.
• Loss of conformation. Non-enzymatic dissociation with EDTA chelates calcium and magnesium to break integrin-mediated adhesion. It removes no peptide, but epitopes whose shape depends on divalent cations can still become undetectable. Antigen preservation therefore has to be designed into the digestion, not assumed from the absence of a protease (Reichard & Asosingh, Cytometry A 2019).

An important consequence: epitope loss is not protein loss. The cell may still express the marker at normal level and simply have lost the piece your clone recognises. This is why a marker can look absent with one antibody clone and normal with another.

Which enzymes cause CD marker loss after dissociation — the published data

Two studies are worth reading in full before you design a digestion around a phenotyping panel.

Human synovial mesenchymal stromal cells, four detachment reagents. Tsuji et al. (Cell Transplantation, 2017) compared trypsin, TrypLE™, collagenase and a non-enzymatic dissociation reagent across incubations from 5 to 120 minutes:

Two details are easy to miss. First, the harm is time-dependent as much as reagent-dependent: trypsin was gentle at 5 minutes and damaging at 30. Second, despite clear antigen loss after 60 minutes of trypsin, the effect on the cells’ multipotency was limited — so “the marker is gone” and “the cell is damaged” are different statements.

Mouse splenocytes, 48 immunological surface molecules. Autengruber et al. (Eur J Microbiol Immunol, 2012) compared collagenase and dispase. Collagenase had only minor effects on most of the 48 markers. Dispase considerably reduced antibody-mediated detection of the majority of them — and the effect was long-lasting: at high dose it was still evident on most markers after 24 hours of culture. High-dose dispase also impaired antigen-specific proliferation of CD4⁺ and CD8⁺ T cells, so the damage was functional, not only analytical.

Related evidence from adjacent fields points the same way. A 6-hour collagenase IV digestion with gentle mechanical dissociation was developed specifically to recover human skin tissue-resident memory T cells with their tissue-specific markers and function intact (Du et al., Front Immunol 2021). And in single-cell RNA-seq, warm collagenase digestion induces a 512-gene stress response, with the authors specifically cautioning that immune-recognition components such as MHC class I may be confounded (O’Flanagan et al., Genome Biol 2019).

The composition problem, which is worse than the epitope problem

Marker loss changes where a gate sits. Differential release changes which cells are in the tube at all, and that error is invisible on the cytometer. In a systematic comparison of mouse kidney dissociation protocols, cold and warm digestion recovered different cell types, and cryopreserving the dissociated suspension caused a major loss of epithelial cells (Denisenko et al., Genome Biol 2020). If one arm of your experiment was dissociated differently from the other, some of the difference you measure belongs to the protocol.

How to tell an epitope artefact from real biology

Six controls, in rough order of how much they tell you per hour spent:

1. Digestion time course. Stain aliquots taken at, for example, 5, 15, 30 and 60 minutes. A marker whose signal falls monotonically with digestion time is being cleaved, not regulated.
2. A non-enzymatic arm. Release the same sample with EDTA or gentle scraping where feasible and compare. Any marker that is bright there and dim after digestion is suspect.
3. Change the antibody clone. Different clones bind different epitopes on the same protein. If a second clone recovers the signal, the protein was there all along — and that clone is the one to use for this workflow.
4. Recovery incubation. Rest the cells 30–60 minutes at 37 °C in complete medium before staining and re-measure. Re-expression confirms cleavage. Note the trade-off: resting cells changes their activation state, so this is a diagnostic, not a fix for every panel.
5. An orthogonal readout. Compare against transcript level, or against immunostaining of intact tissue. Protein present with epitope missing shows up immediately.
6. A spike-in reference. Add a well-characterised reference population to the digestion and stain it alongside. It reports on the digestion itself, independent of your sample’s biology.

Choosing a dissociation reagent when the panel matters

• Shorten before you soften. In the published comparisons, incubation time did as much damage as enzyme identity. Judge the endpoint on the microscope and stop at first release rather than running a fixed clock.
• Use the mildest reagent that actually produces single cells. A gentle reagent that needs 90 minutes is not gentle.
• Lower the temperature where the workflow allows it. Cold digestion slows proteolysis as well as transcription.
• Do not transfer a published ranking to a different cell type. The Tsuji data are from human synovial MSC with a defined panel. Your cells, your clones, your incubation — the ranking has to be re-established once, in your model.
• Keep the protocol identical across arms. One dissociation protocol per experiment, recorded as carefully as the antibody panel.
• Treat animal-origin-free sourcing as a separate question. It matters for regulatory and supply reasons; it says nothing on its own about how an enzyme treats your epitopes.

Where CellTrypase fits — and what we cannot tell you

CellTrypase (Kerry, formerly c-LEcta) is a recombinant, animal-origin-free trypsin-like serine protease: the gene is from Fusarium oxysporum, expressed in a Bacillus sp. host, about 22 kDa, cleaving after lysine and arginine. It is released at ≥95% purity by HPLC and supplied sterile-filtered in PBS with 1.1 mM EDTA, pH 7.1–7.6, 270–320 mOsm/kg, endotoxin ≤1 EU/mL at 1×, mycoplasma negative, sterility passing Ph. Eur. 2.6.1 / USP <71>, stable at least 21 months at 2–8 °C, and quenched by dilution without a trypsin inhibitor.

Here is the part that matters for this article. There is no epitope, CD-marker-retention or flow-cytometry data for CellTrypase — not from the manufacturer, not from us, for any cell type. Its published performance data covers release time, viability and yield in four adherent production lines, plus 2D and 3D human iPSC data in the Kerry technical documents:

Source: c-LEcta / Kerry, CellTrypase Product Information Sheet v4.0 (18 Aug 2026); control is an unnamed current industry-standard trypsin-like enzyme. MDCK is shown as published — 23:32 is a long release time for that line, and we report it unaltered.

Two things follow, and we would rather state them plainly than let the reader infer something better. First, CellTrypase is a trypsin-like enzyme with the same Lys/Arg specificity as other trypsins, so it should be assumed capable of cleaving surface epitopes until tested in your system; the ≥95% purity specification limits proteolytic side activities but is not epitope data. Second, the favourable TrypLE™ result in the Tsuji study is a finding about TrypLE™, not about CellTrypase — we make no claim of equivalence between the two, because no head-to-head study exists.

If surface phenotype is your readout and you want to know how CellTrypase behaves, the only honest answer is a side-by-side test in your own model. A free 100 mL sample is available for qualification, in R&D or GMP grade. A sufficient experiment is small: your current reagent versus CellTrypase, three digestion times, your own panel, reading percentage positive and median fluorescence intensity plus viability, all on the same cells on the same day. For dosing, use approximately 1 mL per 25 cm² and the 1× format; if you substitute it into an existing protocol at the same volume, verify detachment time and viability in your own cell model before switching. Send us the result either way — negative data is worth publishing here too.

Related reading: the CellTrypase vs TrypLE™ comparison, the CellTrypase cell dissociation protocol, and, for choosing an enzyme by tissue, the tissue dissociation enzyme selection guide. Reagents are in the enzymes collection; cell models are in the cell lines collection.

TrypLE™ is a trademark of Thermo Fisher Scientific. Trademarks are used here for identification and comparison only; no endorsement or affiliation is implied. CellTrypase R&D grade is for research use only (RUO) — not for diagnostic or therapeutic use.

Figures 1–4 are illustrative summaries of the cited publications and manufacturer documentation, not new experimental data.

References

1. Tsuji K, et al. Effects of different cell-detaching methods on the viability and cell surface antigen expression of synovial mesenchymal stem cells. Cell Transplant. 2017;26(6):1089–1102. doi:10.3727/096368917X694831
2. Autengruber A, Gereke M, Hansen G, Hennig C, Bruder D. Impact of enzymatic tissue disintegration on the level of surface molecule expression and immune cell function. Eur J Microbiol Immunol. 2012;2(2):112–120. doi:10.1556/EuJMI.2.2012.2.3
3. Reichard A, Asosingh K. Best practices for preparing a single cell suspension from solid tissues for flow cytometry. Cytometry A. 2019;95(2):219–226. doi:10.1002/cyto.a.23690
4. Du W, et al. Rapid isolation of functional human skin tissue-resident memory T lymphocytes. Front Immunol. 2021;12:624013. doi:10.3389/fimmu.2021.624013
5. O’Flanagan CH, et al. Dissociation of solid tumor tissues with cold active protease for single-cell RNA-seq minimizes conserved collagenase-associated stress responses. Genome Biol. 2019;20(1):210. doi:10.1186/s13059-019-1830-0
6. Denisenko E, et al. Systematic assessment of tissue dissociation and storage biases in single-cell and single-nucleus RNA-seq workflows. Genome Biol. 2020;21(1):130. doi:10.1186/s13059-020-02048-6
7. CellTrypase Product Information Sheet v4.0, valid as of 18 Aug 2026. c-LEcta GmbH (Kerry Biotechnology Centre).